Because even that is too much overhead. Non-profits don’t profit because they have to spend every penny they have left over on operating expenses.
Just pay it from our taxes, like the countries with working Healthcare that Rob mentioned in the post. Clearly he has recognized that’s doable, and a surplus wouldn’t be a violation, it would be a surplus for the next year.
Just pay it from our taxes, like the countries with working Healthcare that Rob mentioned in the post
That isn’t how other countries do phrama. They just negotiate the prices.
They don’t do their own R&D, Marketing, or manufacturing, as you are suggesting. They just negotiate pricing.
PPP’s with a range of stakeholders isn’t a bad way to go, just one thought. Those can include private corporations, non-profits, and government-sponsored entities.
Because even that is too much overhead. Non-profits don’t profit because they have to spend every penny they have left over on operating expenses.
Just pay it from our taxes, like the countries with working Healthcare that Rob mentioned in the post. Clearly he has recognized that’s doable, and a surplus wouldn’t be a violation, it would be a surplus for the next year.
That isn’t how other countries do phrama. They just negotiate the prices. They don’t do their own R&D, Marketing, or manufacturing, as you are suggesting. They just negotiate pricing.
I didn’t say countries do their own R&D.
Then who is going to do the R&D?
PPP’s with a range of stakeholders isn’t a bad way to go, just one thought. Those can include private corporations, non-profits, and government-sponsored entities.
What is PPP?